Ennishi, Daisuke
Article History
Received: 2 May 2022
Revised: 21 September 2022
Accepted: 21 September 2022
First Online: 8 October 2022
Declarations
:
: DE has received honoraria from Chugai Pharmaceutical, Kyowa Kirin and Eisai, and has received research funding from Chugai Pharmaceutical and Nippon Shinyaku.